Fresenius Medical Care Announces New Share Buyback Program With a Total Volume of Around EUR 1 Billion With Phased Execution Over 12 Months
May 27, 2026
May 27, 2026
HOMBURG, Germany, May 27 -- Fresenius Medical Care, a provider of products and services for people with chronic kidney failure, issued the following news release:
* * *
Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months
* Total volume of the share buyback is around EUR 1 billion over 12 months
* Share buyback expected to begin in the near future
* * *
Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months
* Total volume of the share buyback is around EUR 1 billion over 12 months
* Share buyback expected to begin in the near future
